Methods for treating disorders associated with the central nervous system using optically pure (-) cisapride
US6066654A · kind A · utility
9Cited by
5References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 10, 1999 |
| Grant date | May 23, 2000 |
| Priority date | — |
| Expiry date | Jun 10, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods are disclosed utilizing the optically pure (-) isomer of cisapride. The (-) isomer of cisapride also exhibits longer duration of action than does racemic cisapride and is useful for treatment of disorders of the central nervous system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.